STEADY-STATE PLASMA-LEVELS OF E-10-OH-NORTRIPTYLINE AND Z-10-OH-NORTRIPTYLINE IN NORTRIPTYLINE-TREATED PATIENTS - SIGNIFICANCE OF CONCURRENT MEDICATION AND THE SPARTEINE OXIDATION PHENOTYPE

被引：32

作者：

GRAM, LF ^{[1
]}

BROSEN, K ^{[1
]}

KRAGHSORENSEN, P ^{[1
]}

CHRISTENSEN, P ^{[1
]}

机构：

[1] ODENSE UNIV,SCH MED,DEPT PSYCHIAT,DK-5000 ODENSE C,DENMARK

来源：

THERAPEUTIC DRUG MONITORING | 1989年 / 11卷 / 05期

关键词：

D O I：

10.1097/00007691-198909000-00003

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：508 / 514

页数：7

共 28 条

[1] PREDICTION OF STEADY-STATE PLASMA LEVELS OF NORTRIPTYLINE FROM SINGLE ORAL DOSE KINETICS - STUDY IN TWINS [J].

ALEXANDERSON, B .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 6 (01) :44-53

[2] RELATIONSHIP BETWEEN PLASMA LEVEL AND THERAPEUTIC EFFECT OF NORTRIPTYLINE [J].

ASBERG, M ;

CRONHOLM, B ;

SJOQVIST, F ;

TUCK, D .

BRITISH MEDICAL JOURNAL, 1971, 3 (5770) :331-&

[3] PRONOUNCED INHIBITION OF NORADRENALINE UPTAKE BY 10-HYDROXY-METABOLITES OF NORTRIPTYLINE [J].

BERTILSSON, L ;

MELLSTROM, B ;

SJOQVIST, F .

LIFE SCIENCES, 1979, 25 (15) :1285-1292

[4] NORTRIPTYLINE AND ANTIPYRINE CLEARANCE IN RELATION TO DEBRISOQUINE HYDROXYLATION IN MAN [J].

BERTILSSON, L ;

EICHELBAUM, M ;

MELLSTROM, B ;

SAWE, J ;

SCHULZ, HU ;

SJOQVIST, F .

LIFE SCIENCES, 1980, 27 (18) :1673-1677

[5] ALPRAZOLAM DOES NOT INHIBIT THE METABOLISM OF NORTRIPTYLINE IN DEPRESSED-PATIENTS OR INHIBIT THE METABOLISM OF DESIPRAMINE IN HUMAN-LIVER MICROSOMES [J].

BERTILSSON, L ;

ABERGWISTEDT, A ;

LIDEN, A ;

OTANI, K ;

SPINA, E .

THERAPEUTIC DRUG MONITORING, 1988, 10 (02) :231-233

[6] STEREOSPECIFIC HYDROXYLATION OF NORTRIPTYLINE IN MAN IN RELATION TO INTERINDIVIDUAL DIFFERENCES IN ITS STEADY-STATE PLASMA LEVEL [J].

BERTILSSON, L ;

ALEXANDERSON, B .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1972, 4 (04) :201-+

[7]

BERTILSSON L, IN PRESS CLIN PHARM

[8] STEADY-STATE PLASMA-CONCENTRATIONS OF CIS-10-OH AND TRANS-10-OH AMITRIPTYLINE METABOLITES [J].

BOCK, JL ;

GILLER, E ;

GRAY, S ;

JATLOW, P .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (05) :609-616

[9]

BROSEN K, 1985, ACTA PHARMACOL TOX, V57, P357

[10] IMIPRAMINE DEMETHYLATION AND HYDROXYLATION - IMPACT OF THE SPARTEINE OXIDATION PHENOTYPE [J].

BROSEN, K ;

OTTON, SV ;

GRAM, LF .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (05) :543-549

← 1 2 3 →